Citius Oncology (CTOR) Cash from Investing Activities (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Cash from Investing Activities of -$600000.0 for Q1 2026, up 86.36% quarter-over-quarter from -$4.4 million in Q4 2025.
Citius Oncology (CTOR) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Cash from Investing Activities for 4 consecutive years, with -$600000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$600000.0; the TTM figure through Mar 2026 stood at $19.8 million (changed N/A YoY), while the FY2025 annual figure was -$5.8 million, down 15.0% from the prior year.
- Cash from Investing Activities climbed to -$600000.0 in Q1 2026 per CTOR's latest filing, from -$4.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $24.7 million in Q1 2024 and bottomed at -$4.4 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged $3.8 million across 4 years, with a median of -$600000.0 in 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn | -2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600,000.00 |
| Mar 31, 2026 | -600,000.00 |
| Dec 31, 2025 | -4.40 Mn |
| Dec 31, 2025 | -4.40 Mn |
| Jun 30, 2024 | 68,644.00 |
| Jun 30, 2024 | 68,644.00 |
| Mar 31, 2024 | 24.74 Mn |
| Mar 31, 2024 | 24.74 Mn |
| Sep 30, 2023 | -660,000.00 |
| Sep 30, 2023 | -660,000.00 |